Matches in SemOpenAlex for { <https://semopenalex.org/work/W2971036678> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W2971036678 endingPage "357" @default.
- W2971036678 startingPage "353" @default.
- W2971036678 abstract "To investigate the remission rate of all-transretinoic acid (ATRA) combined with arsenics acid(ATO) on acute promyelocytic leukemia, and the efficacy and safety of sequential consolidation therapy with idarubicin, all-trans retinoic acid and arsenic trioxide/compound Huangdai tablet.Between January 2011 and January 2016 years 22 patients with newly diagnosed acute promyelocytic leukemia who received ATRA combined with ATO till complete remission in our hospital were retrospectively analyzed. Rates of CR, early mortality, complications and duration of induction were analyzed. The low/intermediate risk patients received 1-2 courses of idarubicin (IDA) single-agent chemotherapy, ATRA and compound Huangdai tablet /ATO alternative treatment of 4 cycles after complete remission; the high-risk patients received idarubicin and cytarabine chemotherapy, ATRA and compound Huangdai tablet /ATO alternative treatment of a total of 4 cycles for double-induction group.Double-induction achieved a 100% CR rates after 28.23±1.6 days induction. During induction, the infection rate was 50%, 36.4% of patients had differentiation syndrome and 27.3% suffered from bleeding in different locations. The 5-year overall survival was 100% and relapse-free survival was 95.4%.This protocol has a good antileukemic effect. The combination of ATRA and ATO achieves extremely high complete reminssion rate and reduces coagulopathy to cut down early mortality. Sequential therapy with IDA, ATRA, and ATO as a consolidation regimen results in satisfactory clinical outcomes with tolerable side effects." @default.
- W2971036678 created "2019-09-05" @default.
- W2971036678 creator A5042315486 @default.
- W2971036678 creator A5069718210 @default.
- W2971036678 creator A5071656221 @default.
- W2971036678 creator A5080121245 @default.
- W2971036678 creator A5088688923 @default.
- W2971036678 date "2017-04-01" @default.
- W2971036678 modified "2023-10-16" @default.
- W2971036678 title "[Efficacy of Idarubicin-Based Stratified Therapy for Acute Promyelocytic Leukemia]." @default.
- W2971036678 doi "https://doi.org/10.7534/j.issn.1009-2137.2017.02.008" @default.
- W2971036678 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28446274" @default.
- W2971036678 hasPublicationYear "2017" @default.
- W2971036678 type Work @default.
- W2971036678 sameAs 2971036678 @default.
- W2971036678 citedByCount "0" @default.
- W2971036678 crossrefType "journal-article" @default.
- W2971036678 hasAuthorship W2971036678A5042315486 @default.
- W2971036678 hasAuthorship W2971036678A5069718210 @default.
- W2971036678 hasAuthorship W2971036678A5071656221 @default.
- W2971036678 hasAuthorship W2971036678A5080121245 @default.
- W2971036678 hasAuthorship W2971036678A5088688923 @default.
- W2971036678 hasConcept C104317684 @default.
- W2971036678 hasConcept C126322002 @default.
- W2971036678 hasConcept C141071460 @default.
- W2971036678 hasConcept C185592680 @default.
- W2971036678 hasConcept C190283241 @default.
- W2971036678 hasConcept C2776601000 @default.
- W2971036678 hasConcept C2776611710 @default.
- W2971036678 hasConcept C2776694085 @default.
- W2971036678 hasConcept C2778041864 @default.
- W2971036678 hasConcept C2779117419 @default.
- W2971036678 hasConcept C2780386689 @default.
- W2971036678 hasConcept C2781121885 @default.
- W2971036678 hasConcept C2781413609 @default.
- W2971036678 hasConcept C55493867 @default.
- W2971036678 hasConcept C71924100 @default.
- W2971036678 hasConcept C90924648 @default.
- W2971036678 hasConceptScore W2971036678C104317684 @default.
- W2971036678 hasConceptScore W2971036678C126322002 @default.
- W2971036678 hasConceptScore W2971036678C141071460 @default.
- W2971036678 hasConceptScore W2971036678C185592680 @default.
- W2971036678 hasConceptScore W2971036678C190283241 @default.
- W2971036678 hasConceptScore W2971036678C2776601000 @default.
- W2971036678 hasConceptScore W2971036678C2776611710 @default.
- W2971036678 hasConceptScore W2971036678C2776694085 @default.
- W2971036678 hasConceptScore W2971036678C2778041864 @default.
- W2971036678 hasConceptScore W2971036678C2779117419 @default.
- W2971036678 hasConceptScore W2971036678C2780386689 @default.
- W2971036678 hasConceptScore W2971036678C2781121885 @default.
- W2971036678 hasConceptScore W2971036678C2781413609 @default.
- W2971036678 hasConceptScore W2971036678C55493867 @default.
- W2971036678 hasConceptScore W2971036678C71924100 @default.
- W2971036678 hasConceptScore W2971036678C90924648 @default.
- W2971036678 hasIssue "2" @default.
- W2971036678 hasLocation W29710366781 @default.
- W2971036678 hasOpenAccess W2971036678 @default.
- W2971036678 hasPrimaryLocation W29710366781 @default.
- W2971036678 hasRelatedWork W1983503531 @default.
- W2971036678 hasRelatedWork W2066578195 @default.
- W2971036678 hasRelatedWork W2144969304 @default.
- W2971036678 hasRelatedWork W2298902517 @default.
- W2971036678 hasRelatedWork W2369322851 @default.
- W2971036678 hasRelatedWork W2409478126 @default.
- W2971036678 hasRelatedWork W2788770029 @default.
- W2971036678 hasRelatedWork W2943626162 @default.
- W2971036678 hasRelatedWork W2971036678 @default.
- W2971036678 hasRelatedWork W2980378359 @default.
- W2971036678 hasVolume "25" @default.
- W2971036678 isParatext "false" @default.
- W2971036678 isRetracted "false" @default.
- W2971036678 magId "2971036678" @default.
- W2971036678 workType "article" @default.